Skip to main content
Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.830
+0.040 (2.23%)
At close: Dec 20, 2024, 4:00 PM
1.880
+0.050 (2.72%)
After-hours: Dec 20, 2024, 7:03 PM EST

Akebia Therapeutics Revenue

Akebia Therapeutics had revenue of $37.43M in the quarter ending September 30, 2024, a decrease of -10.98%. This brings the company's revenue in the last twelve months to $169.88M, down -12.53% year-over-year. In the year 2023, Akebia Therapeutics had annual revenue of $194.62M, down -33.46%.

Revenue (ttm)
$169.88M
Revenue Growth
-12.53%
P/S Ratio
2.19
Revenue / Employee
$1,017,240
Employees
167
Market Cap
399.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023194.62M-97.86M-33.46%
Dec 31, 2022292.48M80.83M38.19%
Dec 31, 2021211.65M-82.99M-28.17%
Dec 31, 2020294.64M-40.36M-12.05%
Dec 31, 2019335.00M127.26M61.26%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Community Health Systems 12.55B
Enhabit 1.04B
Arcturus Therapeutics Holdings 160.40M
National Research 144.16M
Alpha Teknova 36.35M
Nano-X Imaging 10.68M
Allogene Therapeutics 43.00K
Revenue Rankings

AKBA News

More News